Stocks and Investing Stocks and Investing
Thu, August 20, 2020

David Risinger Maintained (ABBV) at Buy with Increased Target to $108 on, Aug 20th, 2020


Published on 2024-10-27 12:25:42 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $95 to $108 on, Aug 20th, 2020.

David has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Initiated at Hold and Held Target at $95 on, Monday, May 18th, 2020


These are the ratings of the 6 analyists that currently disagree with David


  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $127 on, Monday, August 3rd, 2020
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $111 on, Monday, August 3rd, 2020
  • Steve Chesney of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $115 on, Tuesday, June 23rd, 2020
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Wednesday, June 17th, 2020
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $115 on, Tuesday, June 2nd, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Monday, May 11th, 2020
Contributing Sources